Enhanced FOS expression improves tumor clearance and resists exhaustion in NR4A3-deficient CAR T cells under chronic antigen exposure
Science Advances · 17.10.2025 · 11 (42)
DOI: 10.1126/sciadv.adw3571 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 17.10.2025. Verfasst von Peidi Yin und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, P.R. China. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Receptors, Chimeric Antigen, Receptors, Thyroid Hormone, Receptors, Steroid. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The dysfunction of chimeric antigen receptor (CAR) T cells in the tumor microenvironment is a major obstacle to their therapeutic efficacy against solid tumors. Through single-cell RNA sequencing analysis of tumor-infiltrating T cells from patients with glioma, NR4A family genes were identified as closely associated with T cell exhaustion and were coexpressed with dysfunctional genes HAVCR2 and TIGIT . Notably, CAR T cells with NR4A3 knockdown exhibited enhanced cytotoxic activity against tumors, leading to improved tumor clearance and prolonged survival in vivo. However, the promoted antiexhausted phenotype diminished with prolonged tumor burden. This decline in T cell function correlates with the compensatory down-regulation of FOS induced by chronic antigen exposure following NR4A3 knockdown. Overexpressing FOS alongside NR4A3 knockdown robustly boosted the antitumor responses of CAR T cells by skewing their phenotypes and transcriptional profiles away from exhaustion and toward increased effector function. These findings offer a promising strategy for the clinical modification of CAR T cell therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, P.R. China.
- Institute of Pathology, Medical Research Center for Glioma, Southwest Cancer Center, the First Affiliated Hospital (Southwest Hospital) and School of Basic Medical Sciences, Army Medical University (Third Military Medic…
- Intelligent Pathology Institute and Department of Pathology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, China.
- Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA 91010, USA.
- Organoid Innovation Center, CAS Key Laboratory of Nano-Bio Interface, Division of Nanobiomedicine, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou 215123, P.R. China.
- Jiangsu Key Laboratory of Drug Screening, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, P.R. China.
ORCID-Profile: Peidi Yin, Jigui Yang, Yiyang Jiang, Tianchen Xiong, Haofei Liu, Yiliang Fang, Jiayang Wu, Xin Wu, Xindong Liu, Xiu-Wu Bian
Zitieren
APA
Yin, P., Yang, J., Jiang, Y., Han, L., Xiong, T., Liu, H., Fang, Y., Ruan, W., Wu, J., Chen, L., Tan, L., Zuo, Y., Wu, X., Mao, F., Huang, R., Liu, X., & Bian, X. W. (2025). Enhanced FOS expression improves tumor clearance and resists exhaustion in NR4A3-deficient CAR T cells under chronic antigen exposure. Science Advances, 11(42). https://doi.org/10.1126/sciadv.adw3571
Vancouver
Yin P, Yang J, Jiang Y, Han L, Xiong T, Liu H, et al. Enhanced FOS expression improves tumor clearance and resists exhaustion in NR4A3-deficient CAR T cells under chronic antigen exposure. Science Advances. 2025;11(42). doi:10.1126/sciadv.adw3571
BibTeX
@article{Yin2025,
author = {Yin, Peidi and Yang, Jigui and Jiang, Yiyang and Han, Linhong and Xiong, Tianchen and Liu, Haofei and Fang, Yiliang and Ruan, Wenchen and Wu, Jiayang and Chen, Longjuan and Tan, Leyong and Zuo, Yonglin and Wu, Xin and Mao, Fangyuan and Huang, Rui and Liu, Xindong and Bian, Xiu-Wu},
title = {Enhanced FOS expression improves tumor clearance and resists exhaustion in NR4A3-deficient CAR T cells under chronic antigen exposure},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {42},
doi = {10.1126/sciadv.adw3571}
}
EUVIMED